I had an early look at the orders here in the Stevens’ preview. The desks were reporting the market was expecting some jawboning and were wary of a drop … well, we got pretty lame jawboning and the bids have come in a little more confidently now, as expected.
Most Popular
Sponsored
Biogen buys Apellis for $5.3B, adding $689M revenue drugs. Potential $4 CVRs tied to SYFOVRE sales.
Dutch Bros (3.3x P/S) & e.l.f. Beauty (15.5x P/E) offer growth at bargain valuations. MELI's 49% revenue jump at 24.5x P/E.
SHC beats revenue estimates on pricing & demand, but market reacts negatively. Watch margins!
Ackman buys MSFT at 21x forward earnings, seeing value despite AI & Azure concerns. Stock down 17% YTD.
BAE Systems' APKWS rockets surge in price amid high demand; expect boosted profit margins.
Aluminum prices surge 4-yr high, impacting Diet Coke cans & packaging. CO2, fertilizer shortages loom.
RVTY beats EPS, margins soar 39% on strong execution, but revenue guidance drops 5%. Buy?
Sponsored
Must Read
